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Results:
Distance (mm) Group A Group B Group 
C
A 
versus 
B(*)
Annulus to 
maximal 
aneurysmal 
diameter
50.4+/-
16.5
38.4+/-
16.7
NA p<0.0008
Annulus to 
right coronary 
ostium
15.45+/-
5.40
19.95+/-
5.87
14.2+/-
2.3
p<0.0004 p=0.034
Annulus to 
left coronary 
ostium
16.74+/-
2.67
16.84+/-
4.29
14.0+/-
2.4
p<0.0009 p=0.91
Identi¿ ed 
sino-tubular 
junction (STJ)
86.36%  47.36% (100%) p=0.007
Annulus 
to sino-
tubular junc-
tion (when 
identi¿ ed)
22.1+/-
4.1
23.4+/-
7.2
19.5+/-
2.9
p<0.0009 p=0.17
(*): pairwise comparisons following ANOVA
Conclusion: CT analysis shows that patients with BAV usually develop 
AAA above STJ, whereas patients with TAV develop AAA starting at the 
aortic root level. Thus, supra-junctional aortic replacement might often be the 
sound operation for patients with BAV presenting with an AAA.
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Aims: Currently, imaging assessment of patients that underwent a transca-
theter aortic valve implantation (TAVI) is mainly based on echocardiography 
and angiography, both limited to provide a 3-dimensional evaluation of the 
prosthesis within the native valve. The aim of our study was to assess the post-
implantation anatomical characteristics of the Edwards-SAPIEN bioprosthesis 
with multislice computed tomography (MSCT) and to correlate these anato-
mical ¿ ndings to early clinical evolution.
Methods and Results: Thirty-four patients underwent MSCT following 
TAVI. Prosthesis expansion and circularity, depth of implantation, apposition 
degree at the ventriculo-aortic junction, and positioning in relation to coronary 
arteries ostiae were evaluated. Early clinical events such as aortic regurgi-
tation and peri procedural conduction abnormalities were recorded and cor-
related to MSCT ¿ ndings. MSCT provided a comprehensive 3D assessment 
of the prosthesis in 31/34(91%) of patients. Expansion was excellent (mean 
expansion ratio=100.0±10.4%) and increased signi¿ cantly from the ventricular 
side to the aortic side of the prosthesis. Circular deployment was achieved in 
most patients and increased from ventricular to aortic side. Mean implanta-
tion depth was -2.4±2.5 mm, associated with a low rate (12%) of permanent 
pacemaker implantation. Patients with a new conduction abnormality had a 
deepest prosthesis implantation, associated with lesser expansion and circu-
larity. Perfect apposition on MSCT was associated with a low rate of signi¿ -
cant aortic regurgitation.
Conclusion: MSCT is able to provide an accurate 3-dimensional eva-
luation of the prosthesis deployment and positioning after TAVI. Moreover, 
these anatomical findings correlate with the most frequent early com-
plications, i.e. the occurrence of aortic regurgitation and conduction 
abnormalities.
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Aims: Transcatheter aortic valve implantation (TAVI) has become a the-
rapeutic alternative for high-risk patients with severe symptomatic aortic ste-
nosis who cannot bene¿ t from surgery. We present the 30-day results of the 
prospective Rouen single center TAVI registry using the balloon expandable 
Edwards SAPIEN valve according to the new VARC classi¿ cation of TAVI 
complications.
Method and results: Between May 2006 and January 2011, 175 conse-
cutive patients (male n=83, 47%) underwent TAVI in our center, 50 (29%) 
via the transapical (TA) and 125 (71%) via the transfemoral (TF) approach. 
EuroSCORE was slightly higher in the TA than in the TF group: 29.3% vs. 
23.8% (p=0.012). The global procedural success was 97.1%. Major acute 
stroke was diagnosed in 2 (1.1%) patients and minor stroke in 3 (1.7%). 
Acute kidney injury (AKI) class was 0 in the majority of patients: 166 
(94.9%), whereas 5 patients (2.9%) had AKI class 3. Post – TAVI blee-
ding was absent or minor in 92 (52.6%) patients and 28 (16%) had life-
threatening bleeding. Life-threatening bleeding was more frequent in the 
TA than in the TF group: 30% vs. 10.4% (p=0.001). At 30 days, a pace-
maker was implanted in 12 (6.8%) patients. The 30-day mortality for the 
entire cohort was 6.8%, with no significant difference between the TF and 
TA groups: 5.6% vs. 10% (p=0.32). The Kaplan-Meier survival curves are 
presented below.
Conclusion: This real life registry shows that TAVI can be performed 
with a high procedural success and acceptable 30-day complications and 
mortality. Bleeding complication remains the main issue and is more fre-
quently observed in the TA group, probably due to the more invasive nature 
of this approach.
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Ascending aortic aneurysms are dilated following different patterns 
whether the aortic valve is bicuspid or tricuspid.
Implications of the CT scan evaluation for the surgical decision 
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Objectives:  The Bentall procedure is the standard treatment for patients 
presenting with an ascending aortic aneurysm (AAA) associated with 
aortic valve dysfunction, except in cases of insuf¿ cient aortic root dilata-
tion. The extent to which its outcome is inÀ uenced by the valve morpho-
logy remains unknown. The present study was designed to address whether a 
more conservative intervention is appropriate in patients with bicuspid aortic 
valve (BAV).
Methods:  Between October 2005 and March 2009, aortic geometry was 
compared between 41 patients, operated for AAA, of whom 22 had a BAV 
(group A) and 19 a tricuspid aortic valve (TAV) (group B). Forty-two aged-
matched subjects served as controls (group C). Measurements were made by 
using pre-operative ECG-gated thoracic 64 row multi-slice CT scan.  Aortic 
diameters at 10 levels and the distances between the annulus and 5 points 
along the ascending aorta were measured at end diastole.
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Background: Postoperative mediastinitis after cardiac surgery is associated 
with morbidity and mortality. The aim of this study is to identify the risk 
factors for mortality after a diagnosis of postoperative mediastinitis.
Methods: This retrospective cohort study includes all patients who were 
hospitalized in the Intensive Care Unit (ICU) of the Hôpital Européen Georges 
Pompidou (HEGP, Paris, France) and the Centre Cardiologique du Nord (CCN, 
Saint-Denis, France) with postoperative mediastinitis from 2000 to 2008. Post-
operative mediastinitis was de¿ ned as an organ-space infection involving the 
mediastinum and necessitating debridement. The therapeutic management was 
comparable in both centers. Using univariate and multivariate analyses, risk 
factors of mortality during hospitalization were identi¿ ed.
Results: Overall, 310 patients were included (mean age 65 ±12 yrs). The 
logistic EuroSCORE was 7.7 ±9.3. The mortality rate was 21% among the 
patients with mediastinitis. In the multivariate analysis, the independent risk 
factors for mortality were age [OR 1.48], the presence of Gram-negative bacilli 
(GNB) [OR 2.34], the presence of methicillin-resistant Staphylococcus aureus 
(MRSA) [OR 5.51], renal insuf¿ ciency before debridement [OR, 4.46], and a 
complicated ICU course (including mechanical ventilation still being required 
on day 3 and/or amines required in ICU after debridement) [OR 29.03]
Conclusions: Pathogens were major contributing factors to postoperative 
mediastinitis mortality. GNB and MRSA were associated with high rates of morta-
lity. This study illustrates the importance of an antimicrobial prophylaxis regimen 
that is effective against pathogens frequently involved with more severe outcomes.
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The mitral stenosis (MS) is the most common valvular disease in the 
Maghreb; young women of procreation age are most concerned.
Percutaneous mitral commissurotomy (PMC) has changed the prognosis of 
symptomatic MS of pregnant woman.
We report our experience on eighty-three patients requiring PMC during the 
third trimester of pregnancy, between March 1998 and May 2010.
Their mean age was 29±4, 9 years; the presumed age of pregnancy was 
27.5±2.9 weeks of gestation. Fifteen were in New York Heart Association 
class II; ¿ fty in class III and eighteen in class IV. Twelve patients with atrial 
¿ brillation. Wilkins score calculated in all patients with an average 7±2.
No fetal deaths were noted after the procedure. 1 case of stroke, transient. 
No abortions occurred following the procedure.
We report a maternal death ¿ fteen days after delivery. All patients have 
improved after the surgery at least one class of NYHA.
Mitral surface area and hemodynamic parameters improved signi¿ cantly 
after PMC; mean left atrial pressure fell from 30±6.3 to 12.2±7 mmHg, mean 
transmitral gradient from 21±7.2 to 6.1±3.2mmHg and mitral valve area from 
0.8±0.15 to 2.15±0.2 cm2
During pregnancy the PMC is the treatment of choice of MS must be per-
formed by an experienced team because the angle of the trans septal puncture 
is subject to changes in pregnant women.
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Objectives: Cardiac surgery and cardiopulmonary bypass (CPB) induce 
ischemia-reperfusion and subsequent cellular injury with inÀ ammatory reac-
tion. Clinical and experimental studies suggest that recombinant human 
erythropoietin (EPO) independently of its erythropoietic effect may be used 
as a cytoprotective agent against cardiac and cerebral ischemic injury. We 
tested the hypothesis that one large dose of EPO administered shortly before 
CPB prevents the elevation of cardiac and cerebral ischemic blood markers 
as well as the systemic inÀ ammatory response induced by cardiac surgery 
with CBP through this randomized double-blind placebo-controlled pilot 
trial.
Methods: Fifty patients scheduled for coronary artery bypass graft (CABG) 
surgery with CPB were randomly allocated to EPO or control groups. EPO 
(epoietin beta, 800 IU.kg-1 intravenously, EPO group) or placebo (saline, 
control group) was administered before CPB, at the induction of anesthesia. 
The primary end-point was to study the effect of EPO administration on 
several blood markers of myocardial and cerebral ischemia in relation to 
CABG with CPB.
Results: In both groups, surgery increased plasma concentrations of 
cardiac (troponin T, NT-proBNP and creatine kinase-MB. and cerebral 
(S100beta protein) markers ischemic as well as the pro-inÀ ammatory marker 
interleukin-6. Compared with the placebo, EPO administration before CPB did 
not prevent an increase of all these markers following CPB.
Conclusion: One large dose of EPO, given shortly before CPB, did not 
protect against cardiac and cerebral ischemia and inÀ ammatory response 
occurring during CABG surgery with CPB. Although the long-term clinical 
implications remain unknown, the ¿ ndings do not support use of EPO at this 
dose as a cytoprotective agent in patients undergoing cardiac surgery.
0418
Gram-negative bacilli: a new independent risk factor for mortality af-
ter mediastinitis
Etienne Puymirat [Orateur] (1), Hélène Charbonneau (2), Jean Michel 
Maillet (3), Paul Le Besnerais (3), Séverine Peyrard (4), Jean Yves 
Fagon (2), Jean Luc Diehl (2), Emmanuel Guérot (2)
(1) Hôpital Européen Georges Pomipdou (HEGP), Cardiologie, Paris, 
France – (2) Hôpital Européen Georges Pompidou, Réanimation médicale, 
Paris, France – (3) Centre Cardiologique du Nord, Saint Denis, France – 
(4) Hôpital Européen Georges Pompidou, Epidemiologie er recherche cli-
nique, Paris, France
▼
01_corpus_ok.indd   83 26/04/2011   15:50:17
